Olivier Beauchet Selected Research

Memantine (Namenda)

1/2022	Effects of Memantine and High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following Vitamin D Deprivation.
1/2021	Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
1/2016	Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial.
3/2015	Memantine plus vitamin D prevents axonal degeneration caused by lysed blood.
5/2014	Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease.
2/2014	Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate.
11/2013	Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study.
9/2012	Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study.
2/2012	Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.
11/2011	Does memantine improve the gait of individuals with Alzheimer's disease?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Beauchet Research Topics

Disease

23	Cognitive Dysfunction 04/2021 - 11/2003
22	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2006
18	Dementia (Dementias) 01/2021 - 09/2008
6	Chronic Disease (Chronic Diseases) 07/2013 - 04/2010
5	Vitamin D Deficiency 01/2021 - 04/2013
4	Frailty 01/2022 - 09/2011
4	Neoplasms (Cancer) 09/2018 - 01/2011
4	Hypertension (High Blood Pressure) 07/2013 - 09/2011
3	Neurocognitive Disorders (Clerambault Syndrome) 01/2022 - 01/2020
3	Memory Disorders (Memory Loss) 01/2018 - 01/2013
3	Renal Insufficiency (Renal Failure) 01/2015 - 09/2007
2	Mental Disorders (Mental Disorder) 09/2020 - 08/2010
2	Malnutrition (Nutritional Deficiencies) 06/2015 - 06/2011
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2015 - 01/2015
2	Neoplasm Metastasis (Metastasis) 03/2014 - 01/2014
2	Acute Disease 01/2013 - 04/2010
2	Cognition Disorders 01/2013 - 01/2013
2	Osteoporosis 11/2012 - 09/2011
2	Bone Fractures (Bone Fracture) 10/2010 - 09/2009
1	COVID-19 01/2021
1	Inflammation (Inflammations) 11/2020
1	Encephalitis (Encephalitis, Rasmussen) 11/2020
1	Neuroinflammatory Diseases 12/2019
1	Marijuana Abuse (Cannabis Abuse) 12/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2016
1	Infarction (Infarctions) 01/2016
1	Stroke (Strokes) 08/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2015
1	Ganglion Cysts (Ganglion) 01/2015
1	Ischemic Stroke 01/2015
1	Atrial Fibrillation 01/2015
1	Transient Ischemic Attack 01/2015
1	Macular Degeneration (Age-Related Maculopathy) 07/2014
1	Chronic Renal Insufficiency 07/2014
1	Atrophy 05/2014
1	Mobility Limitation (Difficulty Walking) 03/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Fatigue 01/2014
1	Multiple Myeloma 12/2013

Drug/Important Bio-Agent (IBA)

30	Vitamin D FDA LinkGeneric 01/2022 - 09/2009
11	Memantine (Namenda)FDA Link 01/2022 - 10/2011
8	CalciumIBA 12/2019 - 02/2012
7	Psychotropic Drugs (Psychoactive Drugs)IBA 06/2015 - 08/2005
4	Biological ProductsIBA 01/2022 - 01/2011
4	Pharmaceutical PreparationsIBA 11/2020 - 02/2012
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2011
4	CreatinineIBA 03/2014 - 04/2010
3	Parathyroid Hormone (Parathormone)IBA 07/2013 - 08/2010
3	25-hydroxyvitamin DIBA 04/2012 - 07/2010
2	interleukin-1beta-converting enzyme inhibitorIBA 04/2021 - 11/2020
2	SolutionsIBA 01/2021 - 02/2012
2	Amyloid beta-PeptidesIBA 11/2020 - 01/2011
2	Medical MarijuanaIBA 09/2020 - 12/2018
2	Phosphorus (Red Phosphorus)IBA 12/2016 - 07/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 02/2012
2	hydroxide ionIBA 01/2016 - 09/2014
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016 - 05/2014
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2015 - 07/2013
2	AlbuminsIBA 08/2015 - 07/2013
2	Vitamin K FDA Link 08/2015 - 01/2015
2	Neuroprotective AgentsIBA 03/2015 - 02/2014
2	Hormones (Hormone)IBA 01/2015 - 01/2014
2	Galantamine (Galanthamine)FDA LinkGeneric 05/2014 - 05/2008
2	Antihypertensive Agents (Antihypertensives)IBA 07/2013 - 11/2012
2	HydroxycholecalciferolsIBA 01/2013 - 01/2013
2	Cholinergic Antagonists (Anticholinergics)IBA 03/2012 - 06/2007
1	ORALIT (ORS)IBA 01/2022
1	galantide (M 15)IBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 11/2020
1	belnacasanIBA 11/2020
1	4-O-carboxymethylascochlorinIBA 08/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	phenothiazineIBA 12/2019
1	Glial Fibrillary Acidic ProteinIBA 12/2019
1	Methylene Blue (Methylthioninium Chloride)FDA Link 12/2019
1	CaspasesIBA 12/2019
1	Caspase 6IBA 12/2019
1	Indicators and Reagents (Reagents)IBA 06/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 08/2015
1	StrontiumIBA 06/2015
1	fluindioneIBA 01/2015
1	NeurosteroidsIBA 01/2015
1	VitaminsIBA 01/2015
1	Retinaldehyde (Retinal)IBA 01/2015
1	AnticoagulantsIBA 01/2015
1	Rivastigmine (Exelon)FDA LinkGeneric 05/2014
1	Donepezil (Aricept)FDA LinkGeneric 05/2014
1	Drug CombinationsIBA 02/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014

Therapy/Procedure

5	Activities of Daily Living (ADL) 01/2022 - 01/2014
4	Length of Stay 09/2018 - 04/2013
2	Therapeutics 01/2017 - 03/2014
2	Polypharmacy 09/2007 - 08/2005
1	Deprescriptions 01/2020
1	Long-Term Care 01/2020
1	Surgical Instruments (Clip) 01/2015
1	Drug Therapy (Chemotherapy) 03/2014
1	Radiotherapy 03/2014
1	Operative Surgical Procedures 03/2014